|

Secondary Central Nervous System Lymphoma Registry - Charité

RECRUITINGSponsored by Charite University, Berlin, Germany
Actively Recruiting
SponsorCharite University, Berlin, Germany
Started2011-06-08
Est. completion2024-06-08
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05114330

Summary

The objective of the observation is to collect and document data on treatment strategies for secondary central nervous system lymphoma (SCNSL) in routine clinical practice, whether obtained in the context of clinical trials or outside of trials. In particular, the following questions will be specified: * What therapeutic approaches are being pursued? * What is the clinical outcome of the various treatment options? * What is the frequency of serious adverse events with each therapeutic approach?

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

• All patients with SCNSL can and should be included in the registry regardless of which treatment options are used and whether the treatment being given is first-line, recurrence, or maintenance therapy for SCNSL.

Exclusion Criteria:

• None

Conditions3

CancerCentral Nervous System LymphomaNon-hodgkin Lymphoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.